Joura EA, Ulied A, Vandermeulen C, Rua Figueroa M, et al. Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45years of age compared to women 16-26years of age: An open-label phase 3 study. Vaccine 2021 Mar 3. pii: S0264-410X(21)00128.
PMID: 33676783